|
163 |
Commons, Robert J (55153877700); Rajasekhar, Megha (57215545833); Edler, Peta (58608629200); Abreha, Tesfay (14031097700); Awab, Ghulam R (36016082300); Baird, J Kevin (15921267800); Barber, Bridget E (36561132900); Chu, Cindy S (57207278580); Cui, Liwang (57307838700); Daher, André (55411631100); Gonzalez-Ceron, Lilia (55989733200); Grigg, Matthew J (55507854900); Hwang, Jimee (35067936600); Karunajeewa, Harin (6602655545); Lacerda, Marcus V G (8836255900); Ladeia-Andrade, Simone (14025832100); |
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis |
The Lancet Infectious Diseases |
4 |
Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia; WorldWide Antimalarial Resistance Network (WWARN), Asia-Pacific Regional Centre, Melbourne, VIC, Australia; General and Subspecialty Medicine, Grampians Health—Ballarat, Ballarat, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; ICAP, Columbia University Mailman School of Public Health, Addis Ababa, Ethiopia; Mahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nangarhar Medical Faculty, Nangarhar University, Jalalabad, Afghanistan; Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; Shoklo Malaria Research Unit, MORU, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand; Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States; Fiocruz Clinical Research Platform and Vice‑presidency of Research and Biological Collections, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil; Laboratory of Parasitic Diseases, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil; Regional Centre for Public Health Research, National Institute for Public Health, Tapachula, Mexico; US President's Malaria Initiative, Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, GA, United States; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, United States; Department of Medicine-Western Health, Melbourne Medical School, The University of Melbourne, St Albans, VIC, Australia; Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil; Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil; University of Texas Medical Branch, Galveston, TX, United States; Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Lisbon, Portugal; Department of Pharmacology and Therapy, Faculty of Medicine and Veterinary Medicine, Universitas Nusa Cendana, Kupang, Indonesia; Unit of Leishmaniasis and Malaria, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Centro de Pesquisa em Medicina Tropical de Rondônia (CEPEM), Porto Velho, Brazil; Fundação Universidade Federal de Rondônia (UNIR), Porto Velho, Brazil; Department of Pediatrics, Medical Faculty, Universitas Sumatera Utara, Medan, Indonesia; Central Department of Microbiology, Tribhuvan University, Kirtipur, Nepal; Department of Parasitology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; National Institute of Malariology, Parasitology and Entomology, Hanoi, Viet Nam; Federal University of Pará (Universidade Federal do Pará - UFPA), Belém, Brazil; Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam; WWARN, Oxford, United Kingdom; Grupo Malaria, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Facultad Nacional de Salud Publica, Universidad de Antioquia, Medellín, Colombia; Infectious Diseases Data Observatory (IDDO), Oxford, United Kingdom |
NJW, (089179); Shoklo Malaria Research Unit, (220211); Centers for Disease Control and Prevention, CDC; Bill and Melinda Gates Foundation, BMGF; Wellcome Trust, WT; National Health and Medical Research Council, NHMRC, (1194702, 1196068, 2008501, 2016792, 2017436); Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, (223253/Z/21/Z); Capability Systems Centre, CSC |
Funding text 1: RJC, BEB, MJG, JAS, and RNP are supported by Australian National Health and Medical Research Council (NHMRC) Investigator Grants (1194702, 2016792, 2017436, 1196068, and 2008501, respectively). CSC and the Shoklo Malaria Research Unit (grant 220211), and CSC, NJW, and FN (grant 089179) are supported by the Wellcome Trust. JH receives salary support from the US President's Malaria I |
Elsevier Ltd |
Q1 |
|
|
